Author

Marianna Tassinari

Institute of Science and Technology AustriaORCID 0000-0003-2078-9638Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alysson Renato MuotriiD· 1 shared Bernadette BasilicoiD· 1 shared Chiara BerteottiiD· 1 shared Christian Knittl‐FrankiD· 1 shared Daniel MalzliD· 1 shared Elisabetta CianiiD· 1 shared Florian M. PauleriD· 1 shared Gaia NovarinoiD· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alysson Renato MuotriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceCellPeer-reviewedMar 29, 2023

Large neutral amino acid levels tune perinatal neuronal excitability and survival

Lisa S. Knaus, Bernadette Basilico, Daniel Malzl…·Gaia Novarino

The paper investigates how changes in large neutral amino acid metabolism during development affect neuronal excitability and survival, finding that Slc7a5 deletion disrupts lipid metabolism and leads to long-term circuit dysfunction.

70 citationstop 1%

mousemetabolomics

𝕏 PostBluesky

NeurosciencebioRxivPreprintJul 26, 2021

EXPRESSION OF A SECRETABLE, CELL-PENETRATING CDKL5 PROTEIN ENHANCES THE EFFICACY OF AAV VECTOR-MEDIATED GENE THERAPY FOR CDKL5 DEFICIENCY DISORDER.

Giorgio Medici, Marianna Tassinari, Giuseppe Galvani…·Elisabetta Ciani

This study shows that using a secretable TATk-CDKL5 protein in AAV gene therapy improves CDKL5 replacement and functional outcomes in Cdkl5 KO mice compared to native CDKL5 expression.

DOI 10.1101/2021.07.26.453746

mouseprotein sequence

𝕏 PostBluesky